# Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts

> **NCT02181257** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 280 (actual)

## Conditions studied

- Bronchiolitis Obliterans Syndrome (BOS)

## Interventions

- **COMBINATION_PRODUCT:** Extracorporeal Photopheresis (ECP)
- **OTHER:** No intervention in the SOC / Retrospective Chart review.

## Key facts

- **NCT ID:** NCT02181257
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-01
- **Primary completion:** 2027-04
- **Final completion:** 2028-12
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2026-04-06

## Collaborators

- Centers for Medicare and Medicaid Services/ Coverage and Analysis Group
- Therakos, Inc
- The Foundation for Barnes-Jewish Hospital

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02181257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02181257, "Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02181257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*